Entrez Id: |
324 |
Gene Symbol: |
APC |
APC
|
Stomach Neoplasms
|
0.640 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
4595 |
Gene Symbol: |
MUTYH |
MUTYH
|
Stomach Neoplasms
|
0.610 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
1316 |
Gene Symbol: |
KLF6 |
KLF6
|
Stomach Neoplasms
|
0.610 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
843 |
Gene Symbol: |
CASP10 |
CASP10
|
Stomach Neoplasms
|
0.600 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
3659 |
Gene Symbol: |
IRF1 |
IRF1
|
Stomach Neoplasms
|
0.600 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
3557 |
Gene Symbol: |
IL1RN |
IL1RN
|
Stomach Neoplasms
|
0.370 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
1956 |
Gene Symbol: |
EGFR |
EGFR
|
Stomach Neoplasms
|
0.390 |
Biomarker |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
1956 |
Gene Symbol: |
EGFR |
EGFR
|
Stomach Neoplasms
|
0.390 |
Therapeutic |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
1839 |
Gene Symbol: |
HBEGF |
HBEGF
|
Stomach Neoplasms
|
0.310 |
Therapeutic |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
374 |
Gene Symbol: |
AREG |
AREG
|
Stomach Neoplasms
|
0.300 |
Therapeutic |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
7039 |
Gene Symbol: |
TGFA |
TGFA
|
Stomach Neoplasms
|
0.300 |
Therapeutic |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
3576 |
Gene Symbol: |
CXCL8 |
CXCL8
|
Stomach Neoplasms
|
0.300 |
Therapeutic |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
3576 |
Gene Symbol: |
CXCL8 |
CXCL8
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
374 |
Gene Symbol: |
AREG |
AREG
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
"Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells."
|
15723263 |
2005 |
Entrez Id: |
3553 |
Gene Symbol: |
IL1B |
IL1B
|
Stomach Neoplasms
|
0.400 |
Biomarker |
CTD_human |
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
|
19584167 |
2009 |
Entrez Id: |
196 |
Gene Symbol: |
AHR |
AHR
|
Stomach Neoplasms
|
0.310 |
Biomarker |
CTD_human |
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors.
|
12107286 |
2002 |
Entrez Id: |
2950 |
Gene Symbol: |
GSTP1 |
GSTP1
|
Stomach Neoplasms
|
0.310 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
5245 |
Gene Symbol: |
PHB |
PHB
|
Stomach Neoplasms
|
0.310 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
6138 |
Gene Symbol: |
RPL15 |
RPL15
|
Stomach Neoplasms
|
0.310 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
27339 |
Gene Symbol: |
PRPF19 |
PRPF19
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
328 |
Gene Symbol: |
APEX1 |
APEX1
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
10131 |
Gene Symbol: |
TRAP1 |
TRAP1
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
8802 |
Gene Symbol: |
SUCLG1 |
SUCLG1
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
3420 |
Gene Symbol: |
IDH3B |
IDH3B
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
Entrez Id: |
11200 |
Gene Symbol: |
CHEK2 |
CHEK2
|
Stomach Neoplasms
|
0.300 |
Biomarker |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |